Clinical Trial Update: Chronic Posterior Laryngitis With Suspected Laryngopharyngeal Reflux [Phase 4]

View source ↗

Summary

Phase 4 trial assessment of Chronic Posterior Laryngitis with suspected laryngopharyngeal reflux sponsored by AstraZeneca has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posterior Laryngitis

Drugs mentioned

• AstraZeneca Investigational Product

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Posterior Laryngitis (CPL) | Phase 4 | Status: COMPLETED